Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Marks

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Optics Express|June 17, 2009
A family of approximations spanning the Born and Rytov scattering seriesDaniel L Marks
Cancers|May 19, 2019
Pretreatment Cancer-Related Cognitive Impairment-Mechanisms and OutlookBrennan Olson, Daniel L. Marks
Current Opinion in Clinical Nutrition and Metabolic Care|April 20, 2011
Hypothalamic regulation of muscle metabolismTheodore P Braun, Daniel L Marks
Expert Opinion on Investigational Drugs|September 28, 2005
The use of melanocortin antagonists in cachexia of chronic diseaseJarrad M Scarlett, Daniel L Marks
Current Opinion in Supportive and Palliative Care|August 25, 2010
Neuropeptides in the pathophysiology and treatment of cachexiaStephanie M Krasnow, Daniel L Marks
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic diseaseMark D DeBoer, Daniel L Marks
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|January 13, 2018
Mode diversity of weakly modulated cavity antennasDaniel L Marks, David R Smith
Frontiers in Physiology|February 19, 2015
The regulation of muscle mass by endogenous glucocorticoidsTheodore P Braun, Daniel L Marks
Current Opinion in Supportive and Palliative Care|August 8, 2008
Central mechanisms controlling appetite and food intake in a cancer setting: an updateAutumn L Fletcher, Daniel L Marks
Trends in Endocrinology and Metabolism: TEM|June 6, 2006
Cachexia: lessons from melanocortin antagonismMark D Deboer, Daniel L Marks
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Optics Express|June 17, 2009
A family of approximations spanning the Born and Rytov scattering seriesDaniel L Marks
Cancers|May 19, 2019
Pretreatment Cancer-Related Cognitive Impairment-Mechanisms and OutlookBrennan Olson, Daniel L. Marks
Current Opinion in Clinical Nutrition and Metabolic Care|April 20, 2011
Hypothalamic regulation of muscle metabolismTheodore P Braun, Daniel L Marks
Expert Opinion on Investigational Drugs|September 28, 2005
The use of melanocortin antagonists in cachexia of chronic diseaseJarrad M Scarlett, Daniel L Marks
Current Opinion in Supportive and Palliative Care|August 25, 2010
Neuropeptides in the pathophysiology and treatment of cachexiaStephanie M Krasnow, Daniel L Marks
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic diseaseMark D DeBoer, Daniel L Marks
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|January 13, 2018
Mode diversity of weakly modulated cavity antennasDaniel L Marks, David R Smith
Frontiers in Physiology|February 19, 2015
The regulation of muscle mass by endogenous glucocorticoidsTheodore P Braun, Daniel L Marks
Current Opinion in Supportive and Palliative Care|August 8, 2008
Central mechanisms controlling appetite and food intake in a cancer setting: an updateAutumn L Fletcher, Daniel L Marks
Trends in Endocrinology and Metabolism: TEM|June 6, 2006
Cachexia: lessons from melanocortin antagonismMark D Deboer, Daniel L Marks
Pageof 21